Improvement in Skin Fibrosis and Lung Function with Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis

doi:10.1016/j.jtct.2025.02.005

Improvement in Skin Fibrosis and Lung Function with Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis

2025-02-01

0

PRE

AI

DOI：10.1016/j.jtct.2025.02.005

Original

Original request for help

Save

Abstract

En 中文

• Improvement in skin fibrosis with AHSCT versus conventional care persists for several years post-procedure, beyond what was described in existing randomized controlled trials. • This study provides crucial evidence supporting the use of AHSCT as a treatment for SSc in a real-world setting. The findings will contribute to the development of treatment algorithms and clinical guidelines. • This real-world approach underscores the need for further research to investigate the effects of AHSCT on other manifestations of SSc.

Improvement in Skin Fibrosis and Lung Function with Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis

Abstract

Journal

Organization